Contents
- 1 Citation, commencement and interpretation
- 2 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
- 3 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
- 4 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
- 5 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
- 6 Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002
- 7 Amendments to the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973
- 8 Amendments to the Misuse of Drugs (Safe Custody) (Northern Ireland) Regulations 1973
1Citation, commencement and interpretation#
(1)These Regulations may be cited as the Misuse of Drugs (Amendment No.2) and Misuse of Drugs (Safe Custody) (Amendment) Regulations (Northern Ireland) 2014 and shall come into operation on 26th June 2014.
(2)The Interpretation Act (Northern Ireland) 1954 shall apply to these Regulations as it applies to an Act of the Northern Ireland Assembly.
2Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002#
The Misuse of Drugs Regulations (Northern Ireland) 2002 shall be amended as provided by regulations 3 to 6.
3Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002#
In Schedule 1 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27), after paragraph 1(p) insert—“q Any compound (not being benzyl(α-methyl-3,4-methylenedioxyphenethyl)amine) structurally derived from mescaline, 4-bromo-2,5-dimethoxy-α-methylphenethylamine, 2,5-dimethoxy-α,4-dimethylphenethylamine, N-hydroxytenamphetamine, or a compound specified in sub-paragraph (c) or (d) above, by substitution at the nitrogen atom of the amino group with a benzyl substituent, whether or not substituted in the phenyl ring of the benzyl group to any extent.r Any compound (not being a compound for the time being specified in sub- paragraph (c) above) structurally derived from 1-benzofuran, 2,3-dihydro-1-benzofuran, 1H-indole, indoline, 1H-indene, or indane by substitution in the 6-membered ring with a 2-ethylamino substituent whether or not further substituted in the ring system to any extent with alkyl, alkoxy, halide or haloalkyl substituents and whether or not substituted in the ethylamino side-chain with one or more alkyl substituents.”
4Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002#
In Schedule 2 (controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 21, 23, 26 and 27), in paragraph 1 after “Levorphanol” insert—“Lisdexamphetamine”
5Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002#
In Schedule 3 (controlled drugs subject to the requirements of regulations 14, 15 (except Temazepam) 16, 18, 22, 23, 24, 26 and 27), in paragraph 1(a) after “Temazepam” insert—“Tramadol”
6Amendments to the Misuse of Drugs Regulations (Northern Ireland) 2002#
In Schedule 4 (controlled drugs subject to the requirements of regulations 22, 23, 26 and 27), in Part 1, paragraph 1—
(a)After “N-Ethylamphetamine”, insert—“Zaleplon”
(b)After “Zolpidem”, insert—“Zopiclone”
Contains public sector information licensed under the Open Government Licence v3.0.